Filed: 2/14/2025ACC: 0001315863-25-000182
📋 What this filing means
ARMISTICE CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 229 equity positions with a total reported market value of $7.33B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
229
Positions
$7.33B
Total AUM (reported)
286.91M
Total Shares
Allocation by class
COM$2.88B39.3%
RUSSELL 2000 ETF$1.50B20.5%
TR UNIT$1.47B20.0%
SPONSORED ADR$291.47M4.0%
CL A$229.56M3.1%
SHS$193.52M2.6%
COM NEW$177.29M2.4%
Portfolio Concentration
Top 3$3.26B44.4%
4–10$857.49M11.7%
11–25$1.11B15.1%
Rest$2.11B28.8%
Top 3 weight
44.4%
Top 10 weight
56.1%
Voting Authority Distribution
Total shares with voting rights: 286.91M
Sole
Full voting authority
286.91M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole229
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings229
Rows:
ISHARES TR
SOLEShares6.80M
TypeSH
Market value$1.50B
20.50%
Sole
6.80M
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares2.50M
TypeSH
Market value$1.47B
19.99%
Sole
2.50M
Shared
0.00
None
0.00
PTC THERAPEUTICS INC
SOLEShares6.38M
TypeSH
Market value$287.90M
3.93%
Sole
6.38M
Shared
0.00
None
0.00
SUPERNUS PHARMACEUTICALS INC
SOLEShares4.84M
TypeSH
Market value$174.87M
2.39%
Sole
4.84M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares5.22M
TypeSH
Market value$129.31M
1.76%
Sole
5.22M
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares7.36M
TypeSH
Market value$128.18M
1.75%
Sole
7.36M
Shared
0.00
None
0.00
INCYTE CORP
SOLEShares1.77M
TypeSH
Market value$122.10M
1.67%
Sole
1.77M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares892K
TypeSH
Market value$121.76M
1.66%
Sole
892K
Shared
0.00
None
0.00
EXACT SCIENCES CORP
SOLEShares1.62M
TypeSH
Market value$90.86M
1.24%
Sole
1.62M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares1.92M
TypeSH
Market value$90.41M
1.23%
Sole
1.92M
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
SOLEShares224.02K
TypeSH
Market value$90.21M
1.23%
Sole
224.02K
Shared
0.00
None
0.00
ICON PLC
SOLEShares418.11K
TypeSH
Market value$87.68M
1.20%
Sole
418.11K
Shared
0.00
None
0.00
GSK PLC
SOLEShares2.38M
TypeSH
Market value$80.42M
1.10%
Sole
2.38M
Shared
0.00
None
0.00
FIVE9 INC
SOLEShares1.97M
TypeSH
Market value$80.07M
1.09%
Sole
1.97M
Shared
0.00
None
0.00
INARI MED INC
SOLEShares1.57M
TypeSH
Market value$79.92M
1.09%
Sole
1.57M
Shared
0.00
None
0.00
HUMANA INC
SOLEShares312K
TypeSH
Market value$79.16M
1.08%
Sole
312K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares124K
TypeSH
Market value$76.26M
1.04%
Sole
124K
Shared
0.00
None
0.00
GRIFOLS S A
SOLEShares10.04M
TypeSH
Market value$74.67M
1.02%
Sole
10.04M
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
SOLEShares2.26M
TypeSH
Market value$74.41M
1.02%
Sole
2.26M
Shared
0.00
None
0.00
ANHEUSER BUSCH INBEV SA/NV
SOLEShares1.36M
TypeSH
Market value$68.05M
0.93%
Sole
1.36M
Shared
0.00
None
0.00
DENTSPLY SIRONA INC
SOLEShares3.50M
TypeSH
Market value$66.42M
0.91%
Sole
3.50M
Shared
0.00
None
0.00
PENN ENTERTAINMENT INC
SOLEShares3.30M
TypeSH
Market value$65.37M
0.89%
Sole
3.30M
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares1.67M
TypeSH
Market value$62.46M
0.85%
Sole
1.67M
Shared
0.00
None
0.00
NOVO-NORDISK A S
SOLEShares712K
TypeSH
Market value$61.25M
0.84%
Sole
712K
Shared
0.00
None
0.00
SANOFI
SOLEShares1.25M
TypeSH
Market value$60.19M
0.82%
Sole
1.25M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ISHARES TRSOLE | RUSSELL 2000 ETF | 6.80M | SH | $1.50B 20.50% | 6.80M | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 2.50M | SH | $1.47B 19.99% | 2.50M | 0.00 | 0.00 |
PTC THERAPEUTICS INCSOLE | COM | 6.38M | SH | $287.90M 3.93% | 6.38M | 0.00 | 0.00 |
SUPERNUS PHARMACEUTICALS INCSOLE | COM | 4.84M | SH | $174.87M 2.39% | 4.84M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 5.22M | SH | $129.31M 1.76% | 5.22M | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 7.36M | SH | $128.18M 1.75% | 7.36M | 0.00 | 0.00 |
INCYTE CORPSOLE | COM | 1.77M | SH | $122.10M 1.67% | 1.77M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 892K | SH | $121.76M 1.66% | 892K | 0.00 | 0.00 |
EXACT SCIENCES CORPSOLE | COM | 1.62M | SH | $90.86M 1.24% | 1.62M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 1.92M | SH | $90.41M 1.23% | 1.92M | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCSOLE | COM | 224.02K | SH | $90.21M 1.23% | 224.02K | 0.00 | 0.00 |
ICON PLCSOLE | SHS | 418.11K | SH | $87.68M 1.20% | 418.11K | 0.00 | 0.00 |
GSK PLCSOLE | SPONSORED ADR | 2.38M | SH | $80.42M 1.10% | 2.38M | 0.00 | 0.00 |
FIVE9 INCSOLE | COM | 1.97M | SH | $80.07M 1.09% | 1.97M | 0.00 | 0.00 |
INARI MED INCSOLE | COM | 1.57M | SH | $79.92M 1.09% | 1.57M | 0.00 | 0.00 |
HUMANA INCSOLE | COM | 312K | SH | $79.16M 1.08% | 312K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 124K | SH | $76.26M 1.04% | 124K | 0.00 | 0.00 |
GRIFOLS S ASOLE | SP ADR REP B NVT | 10.04M | SH | $74.67M 1.02% | 10.04M | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCSOLE | COM | 2.26M | SH | $74.41M 1.02% | 2.26M | 0.00 | 0.00 |
ANHEUSER BUSCH INBEV SA/NVSOLE | SPONSORED ADR | 1.36M | SH | $68.05M 0.93% | 1.36M | 0.00 | 0.00 |
DENTSPLY SIRONA INCSOLE | COM | 3.50M | SH | $66.42M 0.91% | 3.50M | 0.00 | 0.00 |
PENN ENTERTAINMENT INCSOLE | COM | 3.30M | SH | $65.37M 0.89% | 3.30M | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 1.67M | SH | $62.46M 0.85% | 1.67M | 0.00 | 0.00 |
NOVO-NORDISK A SSOLE | ADR | 712K | SH | $61.25M 0.84% | 712K | 0.00 | 0.00 |
SANOFISOLE | SPONSORED ADR | 1.25M | SH | $60.19M 0.82% | 1.25M | 0.00 | 0.00 |
Page 1 of 10
…